Locoregional treatments for triple-negative breast cancer. by Eiermann, W, Vallis, K

Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades. by Kaufmann, M, von Minckwitz, G, Bergh, J, Conte, P, Darby, S, Eiermann, W, Howell, A, Kiechle, M, Mauri, D, Senn, H, Viale, G, Loibl, S

Breakthroughs in research and treatment of early breast cancer: An overview of the last three decades by Kaufmann, M, Von Minckwitz, G, Loibl, S, Bergh, J, Conte, P, Darby, S, Eiermann, W, Howell, A, Kiechle, M, Mauri, D, Senn, H, Viale, G

Tolerability and efficacy of the trifunctional antibody removab^®(anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/I... by Bois A du, Moiseenko V, Biakhov M, Eiermann W, Ströhlein M, Makhson A, Lichinitser M, Pfisterer J, Schmalfeldt B, Sommer H, Gorbounova V, Burges A, Wimberger P, Kimmig R

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. by Kaufmann, M, von Minckwitz, G, Bear, H, Buzdar, A, McGale, P, Bonnefoi, H, Colleoni, M, Denkert, C, Eiermann, W, Jackesz, R, Makris, A, Miller, W, Pierga, J, Semiglazov, V, Schneeweiss, A, Souchon, R, Stearns, V, Untch, M, Loibl, S